Results 291 to 300 of about 37,731,658 (401)

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome.

New England Journal of Medicine, 2012
Jean Y. Tang, Julian M. Mackay-Wiggan, M. Aszterbaum, R. Yauch, Joselyn A. Lindgren, Kris Chang, C. Coppola, Anita M. Chanana, J. Marji, D. Bickers, E. Epstein   +10 more
semanticscholar   +1 more source

Case Report: Epidermodysplasia verruciformis with multiple squamous and basal cell carcinomas. [PDF]

Front Med (Lausanne)
Zhang Z, Liu C, Li J.
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.

New England Journal of Medicine, 2009
D. V. Von Hoff, P. LoRusso, C. Rudin, J. Reddy, R. Yauch, R. Tibes, G. Weiss, M. Borad, C. Hann, J. Brahmer, H. Mackey, B. Lum, W. Darbonne, J. Marsters, F. D. de Sauvage, J. Low   +15 more
semanticscholar   +1 more source

Long-Term Management of Basal Cell Carcinoma Undergoing Reconstructive Procedures Before the Acquisition of Negative Margins. [PDF]

Cureus
Unal IH, Botsali A, Dogan S, Caliskan E.
europepmc   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

QUANTITATION AND IMMUNOCYTOCHEMICAL LOCALIZATION OF HUMAN SKIN COLLAGENASE IN BASAL CELL CARCINOMA

, 1977
Eugene A. Bauer, James M. Gordon, Max E. Reddick, Arthur Z. Eisen   +3 more
openalex   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Early Recurrence of Nodular Basal Cell Carcinoma Despite Negative Margins: A Case Report. [PDF]

Acta Derm Venereol
Yamamura Y, Fujii K, Nakashima C, Usui S, Otsuka A.   +4 more
europepmc   +1 more source